Diagnóstico prenatal del síndrome de nevo melanocítico congénito: revisión de alcance imagenológica y dermatológica

Autores/as

Palabras clave:

Nevo Pigmentado. Melanosis. Diagnóstico Prenatal. Ultrasonografía Prenatal. Imagen por Resonancia Magnética. Dermatología. Recién Nacido

Resumen

DOI: https://doi.org/10.46296/gt.v9i18.0400

Resumen

Introducción: el síndrome de nevo melanocítico congénito agrupa nevos melanocíticos congénitos con compromiso extracutáneo, especialmente del sistema nervioso central, y su sospecha prenatal es excepcional. Objetivo: mapear la evidencia sobre signos prenatales por ecografía y resonancia magnética fetal, correlacionarlos con la expresión dermatológica neonatal y proponer un enfoque práctico para medicina fetal, radiología, pediatría y dermatología. Metodología: se realizó una revisión de alcance de literatura biomédica indexada y de referencias cruzadas, priorizando reportes con imagen prenatal, neuroimagen posnatal, manifestaciones cutáneas, criterios diagnósticos y recomendaciones de seguimiento. Resultados: la evidencia prenatal se concentró en reportes de caso y mostró tres patrones: quiste de fosa posterior, hiperecogenicidad cerebelosa o amigdaloidea y acortamiento de señal en resonancia fetal compatible con depósitos de melanina. La resonancia posnatal temprana permitió caracterizar melanosis leptomeníngea o intraparenquimatosa antes de que la mielinización redujera la sensibilidad diagnóstica. Discusión: no existen criterios prenatales validados, por lo que el diagnóstico debe plantearse como sospecha diferencial ante hallazgos persistentes del encéfalo posterior o temporal, especialmente si se identifican lesiones cutáneas fetales o alto riesgo neonatal. Conclusiones: la integración de ecografía, resonancia fetal, examen dermatológico neonatal y resonancia cerebral o medular temprana constituye el eje diagnóstico más razonable, aunque se requieren registros multicéntricos para definir sensibilidad, especificidad y seguimiento.

Palabras claves: Nevo Pigmentado. Melanosis. Diagnóstico Prenatal. Ultrasonografía Prenatal. Imagen por Resonancia Magnética. Dermatología. Recién Nacido.

Abstract

Introduction: congenital melanocytic nevus syndrome comprises congenital melanocytic nevi with extracutaneous involvement, especially of the central nervous system, and prenatal suspicion is exceptional. Objective: to map the evidence on prenatal ultrasound and fetal magnetic resonance imaging signs, correlate them with neonatal dermatologic expression, and propose a practical approach for fetal medicine, radiology, pediatrics, and dermatology. Methodology: a scoping review of indexed biomedical literature and citation searching was performed, prioritizing reports with prenatal imaging, postnatal neuroimaging, cutaneous manifestations, diagnostic criteria, and follow-up recommendations. Results: prenatal evidence was concentrated in case reports and showed three patterns: posterior fossa cyst, cerebellar or amygdaloid hyperechogenicity, and fetal magnetic resonance signal shortening compatible with melanin deposits. Early postnatal magnetic resonance imaging allowed characterization of leptomeningeal or intraparenchymal melanosis before myelination reduced diagnostic sensitivity. Discussion: validated prenatal criteria do not exist; therefore, the diagnosis should be considered as a differential suspicion when persistent posterior fossa or temporal brain findings are present, particularly if fetal skin lesions or high neonatal risk are identified. Conclusions: integration of ultrasound, fetal magnetic resonance imaging, neonatal dermatologic examination, and early brain or spine magnetic resonance imaging is the most reasonable diagnostic pathway, although multicenter registries are needed to define sensitivity, specificity, and follow-up.

Keywords: Nevus, Pigmented. Melanosis. Prenatal Diagnosis. Ultrasonography, Prenatal. Magnetic Resonance Imaging. Dermatology. Infant, Newborn.

Información del manuscrito:
Fecha de recepción:
14 de mayo de 2026.
Fecha de aceptación: 20 de julio de 2026.
Fecha de publicación: 27 de agosto de 2026.

Descargas

La descarga de datos todavía no está disponible.

Citas

Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-73.

Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119-26.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Shi Z, Sun T, Yin J, Qiu S, Wang Y, Leng J. Case Report: Prenatal ultrasound presentation of congenital melanocytic nevus syndrome. Front Pediatr. 2024;12:1466999.

East JE, Soares BP. Neurocutaneous melanosis: prenatal presentation as a posterior fossa cyst. Neuropediatrics. 2021;52(6):504-5.

Zhao X, Wang J, Song J, He Y, Zhang X, Ma Q, et al. Prenatal fetal neurocutaneous melanosis: a case report and literature review. Mol Genet Genomic Med. 2026;14:e70174.

Kadonaga JN, Frieden IJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991;24(5 Pt 1):747-55.

Kinsler V, Shaw AC, Merks JH, Hennekam RC. The face in congenital melanocytic nevus syndrome. Am J Med Genet A. 2012;158A(5):1014-9.

Ruth J. Congenital melanocytic nevus syndrome: an association between congenital melanocytic nevi and neurological abnormalities. Semin Pediatr Neurol. 2024;51:101153.

Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441-51.

Mologousis MA, Tsai SYC, Tissera KA, Levin YS, Hawryluk EB. Updates in the management of congenital melanocytic nevi. Children (Basel). 2024;11(1):62.

Takiya M, Fushimi Y, Sakamoto M, Yoshida T, Ueno K, Nakajima S, et al. Incidence of neurocutaneous melanosis in Japanese pediatric patients with congenital melanocytic nevi. Sci Rep. 2023;13:16442.

Fledderus AC, Widdershoven AL, Lapid O, Breugem CC, Pasmans SGMA, van der Horst CMAM, et al. Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysis. Orphanet J Rare Dis. 2022;17:79.

Neale H, Plumptre I, Belazarian L, Wiss K, Hawryluk EB. Central nervous system magnetic resonance imaging abnormalities and neurologic outcomes in pediatric patients with congenital nevi: a 10-year multi-institutional retrospective study. J Am Acad Dermatol. 2022;87(5):1060-8.

Waelchli R, Aylett SE, Atherton D, Thompson DJ, Chong WK, Kinsler VA. Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol. 2015;173(3):739-50.

Ruff C, Gohla G, Nägele T, Batra M. Central nervous system involvement and neuroradiological imaging insights of neurocutaneous melanocytosis in congenital melanocytic nevi. Diagnostics (Basel). 2024;14(21):2345.

Polubothu S, McGuire N, Al-Olabi L, Baird W, Bulstrode N, Chalker J, et al. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi. Br J Dermatol. 2020;182(2):434-43.

Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127(1):179-82.

Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2014;134(4):1067-74.

Salgado CM, Tomás-Velázquez A, Reyes-Múgica M. Congenital melanocytic neoplasms: clinical, histopathological and recent molecular developments. Virchows Arch. 2025;486(1):165-76.

Küsters-Vandevelde HV, Küsters B, van Engen-van Grunsven AC, Groenen PJ, Wesseling P, Blokx WA. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects. Brain Pathol. 2015;25(2):209-26.

Varela-Poblete J, Vidal-Tellez A, Cruz-Quiroga JP, Montoya-Salvadores F, Medina-Escobar J. Melanocytic lesions of the central nervous system: a case series. Arq Neuropsiquiatr. 2022;80(2):153-60.

Barkovich AJ, Frieden IJ, Williams ML. MR of neurocutaneous melanosis. AJNR Am J Neuroradiol. 1994;15(5):859-67.

Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R. Paramagnetic metal scavenging by melanin: MR imaging. Radiology. 1997;204(2):417-23.

Jakchairoongruang K, Khakoo Y, Beckwith M, Barkovich AJ. New insights into neurocutaneous melanosis. Pediatr Radiol. 2018;48(12):1786-96.

Chen YA, Woodley-Cook J, Sgro M, Bharatha A. Sonographic and magnetic resonance imaging findings of neurocutaneous melanosis. Radiol Case Rep. 2016;11(1):29-32.

Guler E, Arslan EA. A case of neurocutaneous melanosis and neuroimaging findings. J Radiol Case Rep. 2015;9(3):1-6.

Mormina E, Granata F, Vinci SL, Coglitore A, Caragliano AA, Tessitore A, et al. Imaging and clinical features of neurocutaneous melanosis in the pediatric population. Curr Med Imaging. 2021;17(12):1391-402.

Bekiesinska-Figatowska M, Szczygielski O, Boczar M, Madzik J, Klepacka T, Zak K, et al. Neurocutaneous melanosis in children with giant congenital melanocytic nevi. Clin Imaging. 2014;38(1):79-84.

Bekiesinska-Figatowska M, Sawicka E, Zak K, Szczygielski O. Age related changes in brain MR appearance in the course of neurocutaneous melanosis. Eur J Radiol. 2016;85(8):1427-31.

Marghoob AA, Dusza S, Oliveria S, Halpern AC. Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol. 2004;140(2):171-5.

Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol. 2005;52(5):793-7.

DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Huang CL, et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol. 1997;36(3 Pt 1):409-16.

Price HN, Schaffer JV. Congenital melanocytic nevi: when to worry and how to treat: facts and controversies. Clin Dermatol. 2010;28(3):293-302.

Ott H, Krengel S, Beck O, Böhler K, Böttcher-Haberzeth S, Cangir Ö, et al. Multidisciplinary long-term care and modern surgical treatment of congenital melanocytic nevi: recommendations by the CMN surgery network. J Dtsch Dermatol Ges. 2019;17(10):1005-16.

Neale H, Wiss K, Belazarian L, Hawryluk EB. Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi. J Am Acad Dermatol. 2024;90(3):e107-e108.

Kinsler VA, O'Hare P, Bulstrode N, Calonje JE, Chong WK, Hargrave D, et al. Melanoma in congenital melanocytic naevi. Br J Dermatol. 2017;176(5):1131-43.

Pastore LM, Valentini R, Marghoob AA. Congenital melanocytic nevi and risk of melanoma. Clin Dermatol. 2025;43(3):378-84.

Ramaswamy V, Delaney H, Haque S, Marghoob A, Khakoo Y. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis. Dev Med Child Neurol. 2012;54(6):563-8.

Rahman RK, Delaney HA, Urban AY, Toescu SM, Aquilina K, Thompson DNP. Neurosurgical management of patients with neurocutaneous melanosis: a systematic review. Neurosurg Focus. 2022;52(4):E8.

Fu YJ, Morota N, Nakagawa A, Takahashi H, Kakita A. Neurocutaneous melanosis: surgical pathological features of an apparently hamartomatous lesion in the amygdala. J Neurosurg Pediatr. 2010;6(1):82-6.

Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, et al. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis. Melanoma Res. 2015;25(5):453-60.

Basu D. Therapeutic strategies in neurocutaneous melanocytosis. Anticancer Res. 2024;44(12):5157-67.

Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2009;124(1 Suppl):1e-13e.

Escandón-Pérez S, Landeta-Sa AP, González-Jasso Y, Arenas-Guzmán R. Giant congenital melanocytic nevi. Bol Med Hosp Infant Mex. 2019;76(6):251-8.

Viana ACL, Gontijo B, Bittencourt FV. Giant congenital melanocytic nevus. An Bras Dermatol. 2013;88(6):863-78.

Ruiz-Maldonado R, Tamayo L, Laterza AM, Durán C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992;120(6):906-11.

Barnhill RL, Fleischli M. Histologic features of congenital melanocytic nevi in infants 1 year of age or younger. J Am Acad Dermatol. 1995;33(5 Pt 1):780-5.

Neuhold JC, Friesenhahn J, Gerdes N, Krengel S. Case reports of fatal or metastasizing melanoma in children and adolescents: a systematic analysis of the literature. Pediatr Dermatol. 2015;32(1):13-22.

Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143.

Publicado

2026-08-27

Cómo citar

Pérez-Mercado, S. A., Romero-Contreras, D. G., Aranda-Sierra, E. A., Gómez-Ramírez, D. C., Benavides-Tacan, W. G., Daza-Cárdenas, V., Solano-Cortés, F. J., Camayo-Rosero, M. A., Ortega-Portilla, L. H., & Cavadia-Padilla, M. del P. (2026). Diagnóstico prenatal del síndrome de nevo melanocítico congénito: revisión de alcance imagenológica y dermatológica. Revista Científica Arbitrada En Investigaciones De La Salud GESTAR. ISSN: 2737-6273., 9(18), 232-251. Recuperado a partir de https://journalgestar.org/index.php/gestar/article/view/375